Hildebrandt, M. A., Lippman, S. M., Etzel, C. J., Kim, E., Lee, J. J., Khuri, F. R., . . . Wu, X. (2012). Genetic variants in the PI3K/PTEN/AKT/MTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention.
Stile di citazione ChicagoHildebrandt, Michelle A.T., et al. Genetic Variants in the PI3K/PTEN/AKT/MTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/recurrence Risk and Response to Retinoid Chemoprevention. 2012.
Citazione MLAHildebrandt, Michelle A.T., et al. Genetic Variants in the PI3K/PTEN/AKT/MTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/recurrence Risk and Response to Retinoid Chemoprevention. 2012.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.